Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica
· Delayed Price · Currency is JMD 3.370
-0.180 (-5.07%)
At close: Mar 12, 2025
Indies Pharma Jamaica Cash Flow Statement
Financials in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2016 - 2019 |
| Net Income | 263.47 | 251.77 | 217.63 | 220.79 | 167.87 | 207.35 | Upgrade
|
| Depreciation & Amortization | 60.67 | 61.44 | 60.16 | 56.84 | 53.73 | 48.9 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.5 | - | -3.07 | -1.88 | -2.4 | - | Upgrade
|
| Other Operating Activities | 39.15 | 39.98 | 72.99 | 59.07 | 62.95 | 10.7 | Upgrade
|
| Change in Accounts Receivable | -19.59 | 8.59 | -103.5 | -5.32 | 60.12 | 71.38 | Upgrade
|
| Change in Inventory | 27.34 | -78.19 | 5.13 | 47.09 | -76.08 | 10.42 | Upgrade
|
| Change in Accounts Payable | -0.27 | -26.01 | 29.26 | 3.03 | -31.49 | 11.56 | Upgrade
|
| Change in Income Taxes | 3.58 | - | - | - | -0.14 | -0.12 | Upgrade
|
| Change in Other Net Operating Assets | -0.77 | -7.57 | 0.88 | -64.39 | 131.91 | -444.3 | Upgrade
|
| Operating Cash Flow | 374.09 | 250.01 | 279.47 | 315.22 | 366.48 | -84.11 | Upgrade
|
| Operating Cash Flow Growth | 104.62% | -10.54% | -11.34% | -13.99% | - | - | Upgrade
|
| Capital Expenditures | -4.07 | -8.88 | -14.02 | -26.37 | -40.72 | -25.41 | Upgrade
|
| Sale of Property, Plant & Equipment | -0.5 | - | 3.53 | 1.88 | 2.98 | 0.7 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -0 | Upgrade
|
| Sale (Purchase) of Intangibles | -45.04 | -19.98 | -62.44 | -61.68 | -202.93 | -114.7 | Upgrade
|
| Investment in Securities | -10.64 | - | 63.14 | 67.31 | 0.75 | -147.5 | Upgrade
|
| Other Investing Activities | 6.92 | 1.62 | 1.46 | 0.95 | 4.84 | -114.31 | Upgrade
|
| Investing Cash Flow | -53.32 | -27.24 | -8.33 | -17.92 | -235.09 | -401.22 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.06 | - | - | 799.58 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 3.43 | 0.6 | 77.05 | Upgrade
|
| Total Debt Issued | -4.9 | - | 0.06 | 3.43 | 0.6 | 876.63 | Upgrade
|
| Short-Term Debt Repaid | - | -0.29 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -41.76 | -46.35 | -48.16 | -46.63 | - | Upgrade
|
| Total Debt Repaid | -42.82 | -42.05 | -46.35 | -48.16 | -46.63 | - | Upgrade
|
| Net Debt Issued (Repaid) | -47.72 | -42.05 | -46.29 | -44.73 | -46.03 | 876.63 | Upgrade
|
| Common Dividends Paid | -146.58 | -146.58 | -150.98 | -150.58 | -146.58 | -186.56 | Upgrade
|
| Other Financing Activities | -63.64 | -63.8 | -56.35 | -56.2 | -61.37 | -9.19 | Upgrade
|
| Financing Cash Flow | -257.94 | -252.42 | -253.62 | -251.5 | -253.99 | 680.89 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0.45 | 0.1 | - | - | Upgrade
|
| Net Cash Flow | 62.83 | -29.65 | 17.98 | 45.89 | -122.59 | 195.56 | Upgrade
|
| Free Cash Flow | 370.02 | 241.13 | 265.45 | 288.85 | 325.76 | -109.52 | Upgrade
|
| Free Cash Flow Growth | 117.42% | -9.16% | -8.10% | -11.33% | - | - | Upgrade
|
| Free Cash Flow Margin | 30.44% | 20.80% | 25.15% | 30.82% | 38.47% | -14.30% | Upgrade
|
| Free Cash Flow Per Share | 0.28 | 0.18 | 0.20 | 0.22 | 0.24 | -0.08 | Upgrade
|
| Cash Interest Paid | 63.64 | 63.8 | 56.35 | 56.2 | 61.37 | 9.19 | Upgrade
|
| Cash Income Tax Paid | 22.16 | 22.16 | -7.87 | 0.32 | - | - | Upgrade
|
| Levered Free Cash Flow | 149.51 | 48.68 | 73.53 | 111.44 | -74.56 | 120.05 | Upgrade
|
| Unlevered Free Cash Flow | 190.26 | 88.97 | 115.27 | 149.24 | -31.46 | 126.16 | Upgrade
|
| Change in Net Working Capital | 7.63 | 120.57 | 37.33 | -4.38 | -22.57 | -81.62 | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.